OTR3
Matrix Therapy Company in Regenerative Medecine
  • Home
  • About us
  • Our Science
    • Technology
    • Pipeline
    • Publications
  • Our Products
    • Human
    • Cacipliq 20®
    • Animals
    • Clerapliq
    • Dermapliq Spray
  • Events & News
  • Contact

Steering Board

Sorry, nothing found.

Search

Recent Posts

  • A Retrospective Self-Controlled Study Evaluating the Prophylactic Effects of CACIPLIQ20 on Postsurgical Scars
  • Apr, 2023 – Publication
  • Dec, 2022 – Clinical
  • A synthetic glycosaminoglycan mimetic (RGTA) modifies natural glycosaminoglycan species during myogenesis
  • Effect of a Matrix Therapy Agent on Corneal Epithelial Healing After Standard Collagen Cross-linking in Patients With Keratoconus: A Randomized Clinical Trial

Recent Comments

    Archives

    • April 2023
    • January 2023
    • May 2022
    • March 2022
    • February 2022
    • November 2021
    • October 2021
    • August 2021
    • June 2021
    • February 2019

    Categories

    • Cacipliq 20
    • CLERAPLIQ
    • DERMAPLIQ
    • Management Team
    • Media Publications
    • News
    • Steering Board

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org